KPIs & Operating Metrics(New)
Breakdown Of AssetsContractual ObligationsEmployee StatisticsGross Margin %Gross Margin Annual %Gross ProfitIncome Before Income TaxesInventoriesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Costs & ExpensesOpex & Costs As A % Of RevenueProperty, Plant And Equipment, Net By Geography AnnualProperty, Plant & Equipment (Gross)Revenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By Major Customers AnnualRevenue By Major Customers Annual %Revenue By ProductRevenue By Product AnnualRevenue By Product Annual %Revenue By RegionRevenue By Region %Revenue By Region AnnualRevenue By Region Annual %Revenue By Therapeutic AreaRevenue By Therapeutic Area Annual
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Gross Profit (2016 - 2025)

Historic Gross Profit for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $6.2 billion.

  • Gilead Sciences' Gross Profit rose 383.52% to $6.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $22.9 billion, marking a year-over-year increase of 630.02%. This contributed to the annual value of $22.5 billion for FY2024, which is 914.25% up from last year.
  • Per Gilead Sciences' latest filing, its Gross Profit stood at $6.2 billion for Q3 2025, which was up 383.52% from $5.6 billion recorded in Q2 2025.
  • Over the past 5 years, Gilead Sciences' Gross Profit peaked at $6.2 billion during Q3 2025, and registered a low of $4.6 billion during Q4 2021.
  • For the 5-year period, Gilead Sciences' Gross Profit averaged around $5.4 billion, with its median value being $5.2 billion (2022).
  • Its Gross Profit has fluctuated over the past 5 years, first tumbled by 2334.38% in 2021, then surged by 2980.29% in 2022.
  • Quarter analysis of 5 years shows Gilead Sciences' Gross Profit stood at $4.6 billion in 2021, then rose by 29.8% to $6.0 billion in 2022, then decreased by 16.17% to $5.0 billion in 2023, then increased by 19.19% to $6.0 billion in 2024, then grew by 3.54% to $6.2 billion in 2025.
  • Its Gross Profit stands at $6.2 billion for Q3 2025, versus $5.6 billion for Q2 2025 and $5.1 billion for Q1 2025.